Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2385]

Skin rash predicts survival benefit from latest lung cancer drug

Skin rash predicts survival benefit from latest lung cancer drug

FDA approves injectable paclitaxel protein-bound particles in combination with carboplatin for NSCLC

FDA approves injectable paclitaxel protein-bound particles in combination with carboplatin for NSCLC

Obesity promotes tumour growth regardless of diet

Obesity promotes tumour growth regardless of diet

Melanomas become resistant to therapy through inflammation-induced dedifferentiation

Melanomas become resistant to therapy through inflammation-induced dedifferentiation

Novel blood-based protein signature determined for rare, aggressive lung cancer

Novel blood-based protein signature determined for rare, aggressive lung cancer

Defects in epithelial barriers drive colorectal cancer growth

Defects in epithelial barriers drive colorectal cancer growth

ESMO 2012: New findings highlight the challenges of managing blood clotting in cancer patients

ESMO 2012: New findings highlight the challenges of managing blood clotting in cancer patients

ESMO 2012: Most cancer patients prepared to delay treatment to benefit from personalised care

ESMO 2012: Most cancer patients prepared to delay treatment to benefit from personalised care

ESMO 2012: Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

ESMO 2012: Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

Predicting erectile dysfunction from prostate cancer treatment

Predicting erectile dysfunction from prostate cancer treatment

More from ecancer